• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成年色素沉着和无色素小鼠眼中的视网膜下给药和电穿孔

Subretinal delivery and electroporation in pigmented and nonpigmented adult mouse eyes.

作者信息

Nickerson John M, Goodman Penny, Chrenek Micah A, Bernal Christiana J, Berglin Lennart, Redmond T Michael, Boatright Jeffrey H

机构信息

Department of Ophthalmology, Emory University, Atlanta, GA, USA.

出版信息

Methods Mol Biol. 2012;884:53-69. doi: 10.1007/978-1-61779-848-1_4.

DOI:10.1007/978-1-61779-848-1_4
PMID:22688698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3722582/
Abstract

Subretinal injection offers one of the best ways to deliver many classes of drugs, reagents, cells and treatments to the photoreceptor, Müller, and retinal pigment epithelium (RPE) cells of the retina. Agents delivered to this space are placed within microns of the intended target cell, accumulating to high concentrations because there is no dilution due to transport processes or diffusion. Dilution in the interphotoreceptor space (IPS) is minimal because the IPS volume is only 10-20 μl in the human eye and less than 1 μl in the mouse eye. For gene delivery purposes, we wished to transfect the cells adjacent to the IPS in adult mouse eyes. Others transfect these cells in neonatal rats to study the development of the retina. In both neonates and adults, electroporation is found to be effective. Here we describe the optimization of electroporation conditions for RPE cells in the adult mouse eye with naked plasmids. However, both techniques, subretinal injection and electroporation, present some technical challenges that require skill on the part of the surgeon to prevent untoward damage to the eye. Here we describe methods that we have used for the past 10 years (Johnson et al. Mol Vis 14: 2211-2226, 2008).

摘要

视网膜下注射是将多种药物、试剂、细胞及治疗手段递送至视网膜光感受器、穆勒细胞和视网膜色素上皮(RPE)细胞的最佳方法之一。注入该区域的药物会积聚在目标细胞的微米范围内,由于不存在运输过程或扩散导致的稀释作用,因此能达到高浓度。光感受器间腔(IPS)内的稀释作用极小,因为人眼的IPS体积仅为10 - 20微升,而小鼠眼的IPS体积小于1微升。为了实现基因递送,我们希望转染成年小鼠眼中IPS附近的细胞。其他人则在新生大鼠中对这些细胞进行转染以研究视网膜的发育。在新生儿和成年人中,电穿孔都被证明是有效的。在此,我们描述了使用裸质粒对成年小鼠眼中RPE细胞进行电穿孔条件的优化。然而,视网膜下注射和电穿孔这两种技术都存在一些技术挑战,需要外科医生具备一定技巧以防止对眼睛造成不良损伤。在此,我们描述了我们在过去10年中所使用的方法(Johnson等人,《分子视觉》14: 2211 - 2226,2008)。

相似文献

1
Subretinal delivery and electroporation in pigmented and nonpigmented adult mouse eyes.成年色素沉着和无色素小鼠眼中的视网膜下给药和电穿孔
Methods Mol Biol. 2012;884:53-69. doi: 10.1007/978-1-61779-848-1_4.
2
DNA delivery in adult mouse eyes: an update with corneal outcomes.成年小鼠眼部的DNA递送:角膜结果的最新进展
Methods Mol Biol. 2014;1121:165-77. doi: 10.1007/978-1-4614-9632-8_15.
3
Technical brief: subretinal injection and electroporation into adult mouse eyes.技术简报:成年小鼠眼内视网膜下注射及电穿孔
Mol Vis. 2008;14:2211-26. Epub 2008 Dec 5.
4
Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.视网膜下注射AAV5载体后的基因治疗不受对侧眼先前玻璃体内注射AAV5载体的影响。
Mol Vis. 2009;15:267-75. Epub 2009 Feb 6.
5
phiC31 integrase confers genomic integration and long-term transgene expression in rat retina.phiC31整合酶可实现基因在大鼠视网膜中的基因组整合及长期转基因表达。
Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2140-6. doi: 10.1167/iovs.04-1252.
6
Apical CLC-2 in retinal pigment epithelium is crucial for survival of the outer retina.视网膜色素上皮细胞顶端的 CLC-2 对于外视网膜的存活至关重要。
FASEB J. 2021 Jul;35(7):e21689. doi: 10.1096/fj.202100349R.
7
[In vivo electroporation of newborn mouse retina].[新生小鼠视网膜的体内电穿孔]
Yi Chuan. 2014 Nov;36(11):1173-8. doi: 10.3724/SP.J.1005.2014.1173.
8
Transplantation of human fetal retinal pigment epithelium rescues photoreceptor cells from degeneration in the Royal College of Surgeons rat retina.人胎儿视网膜色素上皮移植可挽救皇家外科学院大鼠视网膜中光感受器细胞的退化。
Invest Ophthalmol Vis Sci. 1996 Jan;37(1):204-11.
9
Neonatal systemic delivery of scAAV9 in rodents and large animals results in gene transfer to RPE cells in the retina.在啮齿动物和大动物中经全身途径给予 scAAV9 可将基因递送至视网膜中的 RPE 细胞。
Exp Eye Res. 2011 Oct;93(4):491-502. doi: 10.1016/j.exer.2011.06.012. Epub 2011 Jun 24.
10
Nonviral ocular gene transfer.非病毒眼部基因转移
Gene Ther. 2005 May;12(10):843-51. doi: 10.1038/sj.gt.3302475.

引用本文的文献

1
An improved method of transducing retinal ganglion cells using AAV via transpupillary injection in adult mouse eyes.一种通过经瞳孔注射腺相关病毒(AAV)在成年小鼠眼中转导视网膜神经节细胞的改进方法。
Mol Vis. 2025 Jan 12;31:1-9. eCollection 2025.
2
Autosomal-dominant macular dystrophy linked to a chromosome 17 tandem duplication.与17号染色体串联重复相关的常染色体显性黄斑营养不良。
JCI Insight. 2024 Dec 6;9(23):e178768. doi: 10.1172/jci.insight.178768.
3
Transpupillary-Guided Trans-Scleral Transplantation of Subretinal Grafts in a Retinal Degeneration Mouse Model.

本文引用的文献

1
Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab.采用玻璃体切除术、黄斑下注射组织型纤溶酶原激活剂(tPA)继以玻璃体内注射雷珠单抗治疗年龄相关性黄斑变性相关的黄斑下出血移位
Clin Ophthalmol. 2010 Jul 21;4:637-42. doi: 10.2147/opth.s10060.
2
Tissue plasminogen activator-assisted vitrectomy: surgical drainage of submacular hemorrhage.组织型纤溶酶原激活剂辅助玻璃体切除术:黄斑下出血的手术引流
Dev Ophthalmol. 2009;44:82-88. doi: 10.1159/000223948. Epub 2009 Jun 3.
3
Technical brief: subretinal injection and electroporation into adult mouse eyes.
经瞳孔引导的巩膜移植术在视网膜变性小鼠模型中眼内视网膜下移植
J Vis Exp. 2024 Jan 26(203). doi: 10.3791/65448.
4
Non-Viral Delivery of CRISPR/Cas Cargo to the Retina Using Nanoparticles: Current Possibilities, Challenges, and Limitations.使用纳米颗粒将CRISPR/Cas物质非病毒递送至视网膜:当前的可能性、挑战及局限性
Pharmaceutics. 2022 Sep 1;14(9):1842. doi: 10.3390/pharmaceutics14091842.
5
Subretinal injection in mice to study retinal physiology and disease.视网膜下腔注射在研究视网膜生理和疾病中的应用。
Nat Protoc. 2022 Jun;17(6):1468-1485. doi: 10.1038/s41596-022-00689-4. Epub 2022 Apr 13.
6
The Landscape of Non-Viral Gene Augmentation Strategies for Inherited Retinal Diseases.遗传性视网膜疾病的非病毒基因增强策略全景。
Int J Mol Sci. 2021 Feb 26;22(5):2318. doi: 10.3390/ijms22052318.
7
Nanotechnology in retinal drug delivery.视网膜药物递送中的纳米技术。
Int J Ophthalmol. 2018 Jun 18;11(6):1038-1044. doi: 10.18240/ijo.2018.06.23. eCollection 2018.
8
Clustered Regularly Interspaced Short Palindromic Repeats: Challenges in Treating Retinal Disease.簇状规律间隔短回文重复序列:治疗视网膜疾病的挑战。
Asia Pac J Ophthalmol (Phila). 2016 Jul-Aug;5(4):304-8. doi: 10.1097/APO.0000000000000225.
9
A Novel, Real-Time, In Vivo Mouse Retinal Imaging System.一种新型的实时活体小鼠视网膜成像系统。
Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7159-68. doi: 10.1167/iovs.14-16370.
10
Advances in retinal ganglion cell imaging.视网膜神经节细胞成像的进展。
Eye (Lond). 2015 Oct;29(10):1260-9. doi: 10.1038/eye.2015.154. Epub 2015 Aug 21.
技术简报:成年小鼠眼内视网膜下注射及电穿孔
Mol Vis. 2008;14:2211-26. Epub 2008 Dec 5.
4
Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics.针对RPE65异构酶缺乏症的人类基因疗法可激活视觉的视黄醛循环,但视杆动力学缓慢。
Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15112-7. doi: 10.1073/pnas.0807027105. Epub 2008 Sep 22.
5
Effect of gene therapy on visual function in Leber's congenital amaurosis.基因治疗对莱伯先天性黑蒙视觉功能的影响。
N Engl J Med. 2008 May 22;358(21):2231-9. doi: 10.1056/NEJMoa0802268. Epub 2008 Apr 27.
6
Safety and efficacy of gene transfer for Leber's congenital amaurosis.基因转移治疗莱伯先天性黑蒙的安全性和有效性。
N Engl J Med. 2008 May 22;358(21):2240-8. doi: 10.1056/NEJMoa0802315. Epub 2008 Apr 27.
7
Introduction of large insert DNA into mammalian cells and embryos.将大片段DNA导入哺乳动物细胞和胚胎。
Curr Protoc Hum Genet. 2001 Nov;Chapter 5:Unit 5.12. doi: 10.1002/0471142905.hg0512s30.
8
A new approach towards a minimal invasive retina implant.一种用于微创视网膜植入物的新方法。
J Neural Eng. 2007 Mar;4(1):S30-7. doi: 10.1088/1741-2560/4/1/S05. Epub 2007 Feb 20.
9
Intravital imaging of fluorescent markers and FRET probes by DNA tattooing.通过DNA纹身对荧光标记物和FRET探针进行活体成像。
BMC Biotechnol. 2007 Jan 3;7:2. doi: 10.1186/1472-6750-7-2.
10
Non-viral ocular gene therapy: potential ocular therapeutic avenues.非病毒眼部基因治疗:潜在的眼部治疗途径。
Adv Drug Deliv Rev. 2006 Nov 15;58(11):1224-42. doi: 10.1016/j.addr.2006.07.023. Epub 2006 Sep 16.